{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Copyright 2025 Google LLC."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:43:23.741391Z",
     "iopub.status.busy": "2025-11-29T16:43:23.741110Z",
     "iopub.status.idle": "2025-11-29T16:43:23.923447Z",
     "shell.execute_reply": "2025-11-29T16:43:23.922409Z",
     "shell.execute_reply.started": "2025-11-29T16:43:23.741362Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Google API key set successfully!\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from getpass import getpass\n",
    "\n",
    "GOOGLE_API_KEY = getpass(\"Enter your GOOGLE API KEY: \")\n",
    "\n",
    "os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n",
    "print(\" Google API key set successfully!\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### 1.3: Import ADK components\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:43:35.249317Z",
     "iopub.status.busy": "2025-11-29T16:43:35.248902Z",
     "iopub.status.idle": "2025-11-29T16:44:29.238455Z",
     "shell.execute_reply": "2025-11-29T16:44:29.237106Z",
     "shell.execute_reply.started": "2025-11-29T16:43:35.249275Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " ADK components imported successfully.\n"
     ]
    }
   ],
   "source": [
    "from typing import Any, Dict\n",
    "\n",
    "from google.adk.agents import Agent, LlmAgent\n",
    "from google.adk.apps.app import App, EventsCompactionConfig\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.sessions import DatabaseSessionService\n",
    "from google.adk.sessions import InMemorySessionService\n",
    "from google.adk.runners import Runner\n",
    "from google.adk.tools.tool_context import ToolContext\n",
    "from google.genai import types\n",
    "\n",
    "print(\" ADK components imported successfully.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 1.4: Helper functions\n",
    "\n",
    "Helper function that manages a complete conversation session, handling session\n",
    "creation/retrieval, query processing, and response streaming. It supports\n",
    "both single queries and multiple queries in sequence.\n",
    "\n",
    "Example:\n",
    "\n",
    "```\n",
    ">>> await run_session(runner, \"What is the capital of France?\", \"geography-session\")\n",
    ">>> await run_session(runner, [\"Hello!\", \"What's my name?\"], \"user-intro-session\")\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:44:36.712578Z",
     "iopub.status.busy": "2025-11-29T16:44:36.711204Z",
     "iopub.status.idle": "2025-11-29T16:44:36.721880Z",
     "shell.execute_reply": "2025-11-29T16:44:36.721078Z",
     "shell.execute_reply.started": "2025-11-29T16:44:36.712542Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Helper functions defined.\n"
     ]
    }
   ],
   "source": [
    "\n",
    "async def run_session(\n",
    "    runner_instance: Runner,\n",
    "    user_queries: list[str] | str = None,\n",
    "    session_name: str = \"default\",\n",
    "):\n",
    "    print(f\"\\n ### Session: {session_name}\")\n",
    "\n",
    "    # Get app name from the Runner\n",
    "    app_name = runner_instance.app_name\n",
    "\n",
    "    # Attempt to create a new session or retrieve an existing one\n",
    "    try:\n",
    "        session = await session_service.create_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "    except:\n",
    "        session = await session_service.get_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "\n",
    "    # Process queries if provided\n",
    "    if user_queries:\n",
    "\n",
    "        if type(user_queries) == str:\n",
    "            user_queries = [user_queries]\n",
    "\n",
    "       \n",
    "        for query in user_queries:\n",
    "            print(f\"\\nUser > {query}\")\n",
    "\n",
    "          \n",
    "            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n",
    "\n",
    "      \n",
    "            async for event in runner_instance.run_async(\n",
    "                user_id=USER_ID, session_id=session.id, new_message=query\n",
    "            ):\n",
    "                \n",
    "                if event.content and event.content.parts:\n",
    "                    \n",
    "                    if (\n",
    "                        event.content.parts[0].text != \"None\"\n",
    "                        and event.content.parts[0].text\n",
    "                    ):\n",
    "                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n",
    "    else:\n",
    "        print(\"No queries!\")\n",
    "\n",
    "\n",
    "print(\" Helper functions defined.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 1.5: Configure Retry Options\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:44:41.291533Z",
     "iopub.status.busy": "2025-11-29T16:44:41.291084Z",
     "iopub.status.idle": "2025-11-29T16:44:41.297791Z",
     "shell.execute_reply": "2025-11-29T16:44:41.296557Z",
     "shell.execute_reply.started": "2025-11-29T16:44:41.291499Z"
    },
    "trusted": true
   },
   "outputs": [],
   "source": [
    "retry_config = types.HttpRetryOptions(\n",
    "    attempts=5, \n",
    "    exp_base=7,  \n",
    "    initial_delay=1,\n",
    "    http_status_codes=[429, 500, 503, 504],  \n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2.4 Implementing Our First Stateful Agent\n",
    "\n",
    "with a simple Session Management option (`InMemorySessionService`):"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:44:46.831708Z",
     "iopub.status.busy": "2025-11-29T16:44:46.831422Z",
     "iopub.status.idle": "2025-11-29T16:44:46.841074Z",
     "shell.execute_reply": "2025-11-29T16:44:46.840092Z",
     "shell.execute_reply.started": "2025-11-29T16:44:46.831688Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Stateful agent initialized!\n",
      "   - Application: default\n",
      "   - User: default\n",
      "   - Using: InMemorySessionService\n"
     ]
    }
   ],
   "source": [
    "APP_NAME = \"default\"  \n",
    "USER_ID = \"default\"  \n",
    "SESSION = \"default\"  \n",
    "\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "\n",
    "\n",
    "root_agent = Agent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot\",  \n",
    ")\n",
    "\n",
    "session_service = InMemorySessionService()\n",
    "\n",
    "runner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\" Stateful agent initialized!\")\n",
    "print(f\"   - Application: {APP_NAME}\")\n",
    "print(f\"   - User: {USER_ID}\")\n",
    "print(f\"   - Using: {session_service.__class__.__name__}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2.5 Testing Our Stateful Agent\n",
    "\n",
    "Now let's see the magic of sessions in action!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:45:15.551761Z",
     "iopub.status.busy": "2025-11-29T16:45:15.551460Z",
     "iopub.status.idle": "2025-11-29T16:45:16.745099Z",
     "shell.execute_reply": "2025-11-29T16:45:16.744187Z",
     "shell.execute_reply.started": "2025-11-29T16:45:15.551739Z"
    },
    "lines_to_next_cell": 2,
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: stateful-agentic-session\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of United States?\n",
      "gemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi, I am Sam! What is the capital of United States?\",\n",
    "        \"Hello! What is my name?\",  \n",
    "    ],\n",
    "    \"stateful-agentic-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Agent's forgetfulness\n",
    "\n",
    "> To verify that the agent forgets the conversation, **restart the kernel**. Then, **run ALL the previous cells in this notebook EXCEPT the above cell\n",
    "\n",
    "run the below cell to check the forgetfulness"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:44:54.991084Z",
     "iopub.status.busy": "2025-11-29T16:44:54.990735Z",
     "iopub.status.idle": "2025-11-29T16:44:55.736790Z",
     "shell.execute_reply": "2025-11-29T16:44:55.735802Z",
     "shell.execute_reply.started": "2025-11-29T16:44:54.991059Z"
    },
    "lines_to_next_cell": 2,
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: stateful-agentic-session\n",
      "\n",
      "User > What did I ask you about earlier?\n",
      "gemini-2.5-flash-lite >  You asked me about the capital of the United States and what your name is.\n",
      "\n",
      "User > And remind me, what's my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam.\n"
     ]
    }
   ],
   "source": [
    "# Run this cell after restarting the kernel. All this history will be gone...\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n",
    "    \"stateful-agentic-session\",\n",
    ")  "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### The Problem \n",
    "To achieve this, we must persist information. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: aiosqlite in c:\\users\\hp\\appdata\\local\\programs\\python\\python312\\lib\\site-packages (0.21.0)Note: you may need to restart the kernel to use updated packages.\n",
      "\n",
      "Requirement already satisfied: typing_extensions>=4.0 in c:\\users\\hp\\appdata\\local\\programs\\python\\python312\\lib\\site-packages (from aiosqlite) (4.15.0)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n",
      "[notice] A new release of pip is available: 25.0.1 -> 25.3\n",
      "[notice] To update, run: python.exe -m pip install --upgrade pip\n"
     ]
    }
   ],
   "source": [
    "pip install aiosqlite\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Implementing Persistent Sessions\n",
    "\n",
    "using DatabaseSessionService using SQLite. \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:57:24.037717Z",
     "iopub.status.busy": "2025-11-29T16:57:24.036635Z",
     "iopub.status.idle": "2025-11-29T16:57:24.155858Z",
     "shell.execute_reply": "2025-11-29T16:57:24.154778Z",
     "shell.execute_reply.started": "2025-11-29T16:57:24.037666Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Upgraded to persistent sessions!\n",
      "   - Database: my_agent_data.db\n",
      "   - Sessions will survive restarts!\n"
     ]
    }
   ],
   "source": [
    "\n",
    "chatbot_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot with persistent memory\",\n",
    ")\n",
    "\n",
    "db_url = \"sqlite+aiosqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "\n",
    "runner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\" Upgraded to persistent sessions!\")\n",
    "print(f\"   - Database: my_agent_data.db\")\n",
    "print(f\"   - Sessions will survive restarts!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Verifying Persistence\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T16:59:29.352391Z",
     "iopub.status.busy": "2025-11-29T16:59:29.352034Z",
     "iopub.status.idle": "2025-11-29T16:59:30.401072Z",
     "shell.execute_reply": "2025-11-29T16:59:30.400135Z",
     "shell.execute_reply.started": "2025-11-29T16:59:29.352368Z"
    },
    "lines_to_next_cell": 2,
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of the United States?\n",
      "gemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Resuming a Conversation\n",
    "\n",
    "> let's stop this Notebook's kernel and restart it again.**\n",
    ">\n",
    "> Run all the previous cells in the notebook, EXCEPT the previous Section 3.3 above cell\n",
    ">\n",
    "> 2. Now, run the below cell with the **same session ID** (`test-db-session-01`).**Because the session is loaded from the database, the agent should still remember** \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T17:00:17.052970Z",
     "iopub.status.busy": "2025-11-29T17:00:17.052610Z",
     "iopub.status.idle": "2025-11-29T17:00:18.229462Z",
     "shell.execute_reply": "2025-11-29T17:00:18.228311Z",
     "shell.execute_reply.started": "2025-11-29T17:00:17.052942Z"
    },
    "lines_to_next_cell": 2,
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > What is the capital of India?\n",
      "gemini-2.5-flash-lite >  The capital of India is New Delhi.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### the session data is isolated\n",
    "\n",
    "a session is private conversation between an Agent and a User. Let's run our `run_session` with a different session name `test-db-session-02` to confirm this.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T17:14:08.672542Z",
     "iopub.status.busy": "2025-11-29T17:14:08.672178Z",
     "iopub.status.idle": "2025-11-29T17:14:09.199934Z",
     "shell.execute_reply": "2025-11-29T17:14:09.198945Z",
     "shell.execute_reply.started": "2025-11-29T17:14:08.672518Z"
    },
    "lines_to_next_cell": 2,
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-02\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n",
    ")  "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 3.6 How are the events stored in the Database?\n",
    "\n",
    "Since we are using a sqlite DB to store information, let's have a quick peek to see how information is stored."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T18:04:46.472113Z",
     "iopub.status.busy": "2025-11-29T18:04:46.471731Z",
     "iopub.status.idle": "2025-11-29T18:04:46.481463Z",
     "shell.execute_reply": "2025-11-29T18:04:46.479701Z",
     "shell.execute_reply.started": "2025-11-29T18:04:46.472087Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['app_name', 'session_id', 'author', 'content']\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'text_chat_bot', '{\"parts\": [{\"text\": \"The field of AI in healthcare is incredibly dynamic, with new developments emerging constantly. To give you the most relevant and \\\\\"latest\\\\\" news, I need a bit more information about what you\\'re most interested in.\\\\n\\\\nHowever, I can provide a general overview of some of the most active and impactful areas of AI in healthcare right now, based on recent trends:\\\\n\\\\n**Key Areas of AI Advancement in Healthcare:**\\\\n\\\\n*   **Drug Discovery and Development:**\\\\n    *   **Accelerated Research:** AI is significantly speeding up the identification of potential drug candidates, predicting their efficacy, and optimizing clinical trial design. Companies are using AI to analyze vast biological datasets and molecular structures.\\\\n    *   **Personalized Medicine:** AI is crucial for tailoring drug treatments to an individual\\'s genetic makeup, lifestyle, and disease profile, leading to more effective therapies and fewer side effects.\\\\n*   **Diagnostics and Medical Imaging:**\\\\n    *   **Enhanced Image Analysis:** AI algorithms are becoming incredibly adept at detecting subtle anomalies in medical images (X-rays, CT scans, MRIs, pathology slides) that might be missed by the human eye. This is improving the accuracy and speed of diagnoses for conditions like cancer, diabetic retinopathy, and neurological disorders.\\\\n    *   **Early Disease Detection:** AI models are being developed to identify early signs of disease from various data sources, including electronic health records (EHRs) and wearable devices, enabling proactive interventions.\\\\n*   **Personalized Treatment and Patient Care:**\\\\n    *   **Predictive Analytics:** AI can predict patient outcomes, identify individuals at high risk of hospital readmission or developing certain complications, allowing for targeted interventions.\\\\n    *   **Virtual Assistants and Chatbots:** AI-powered tools are being used for patient engagement, appointment scheduling, medication reminders, and providing basic health information, freeing up healthcare professionals\\' time.\\\\n    *   **Robotics in Surgery:** AI is enhancing robotic surgical systems, enabling greater precision, minimally invasive procedures, and potentially faster recovery times.\\\\n*   **Operational Efficiency and Administration:**\\\\n    *   **Streamlining Workflows:** AI is automating administrative tasks like medical coding, billing, and appointment scheduling, reducing burnout among healthcare staff.\\\\n    *   **Resource Optimization:** AI can help hospitals manage resources more effectively, predicting patient flow and optimizing staffing levels.\\\\n    *   **Fraud Detection:** AI algorithms are being used to identify fraudulent claims and billing practices.\\\\n*   **Generative AI in Healthcare:**\\\\n    *   **Clinical Documentation:** Large language models (LLMs) are being explored for summarizing patient notes, generating reports, and assisting with medical scribing.\\\\n    *   **Medical Education:** LLMs can create realistic patient scenarios for training medical students and professionals.\\\\n    *   **Research Synthesis:** AI can help researchers quickly synthesize information from numerous scientific papers.\\\\n\\\\n**Recent Trends and News Highlights (General Themes):**\\\\n\\\\n*   **FDA Approvals:** More AI-powered medical devices and software are receiving FDA clearance and approval, signaling a growing acceptance and validation of these technologies.\\\\n*   **Partnerships and Investments:** Major tech companies, pharmaceutical giants, and healthcare providers are investing heavily in AI startups and forming strategic partnerships to develop and deploy AI solutions.\\\\n*   **Focus on Explainability and Trust:** As AI becomes more integrated into clinical decision-making, there\\'s a growing emphasis on making AI models more transparent and explainable (\\\\\"explainable AI\\\\\" or XAI) to build trust among clinicians and patients.\\\\n*   **Ethical Considerations and Regulation:** Discussions around data privacy, algorithmic bias, and the ethical implications of AI in healthcare are intensifying, leading to a greater focus on regulatory frameworks.\\\\n*   **AI for Mental Health:** AI is being explored for early detection, personalized interventions, and providing accessible support for mental health conditions.\\\\n\\\\n**To get more specific news, could you tell me:**\\\\n\\\\n*   Are you interested in a particular disease or condition (e.g., cancer, cardiology, neurology)?\\\\n*   Are you curious about a specific type of AI application (e.g., diagnostics, drug discovery, patient monitoring)?\\\\n*   Are you looking for news about specific companies or research institutions?\\\\n*   Are you interested in the regulatory landscape or ethical debates surrounding AI in healthcare?\\\\n\\\\nOnce I have a better understanding of your interests, I can try to provide more tailored and up-to-date information.\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"Are there any new developments in drug discovery?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'text_chat_bot', '{\"parts\": [{\"text\": \"Yes, absolutely! Drug discovery is one of the most exciting and rapidly evolving areas where AI is making a significant impact. Here are some of the latest developments and trends in AI-driven drug discovery:\\\\n\\\\n**Key Areas of Recent Advancement:**\\\\n\\\\n1.  **Accelerated Target Identification and Validation:**\\\\n    *   **Genomic and Proteomic Data Analysis:** AI algorithms can sift through massive datasets of genomic, proteomic, and transcriptomic information to identify novel disease targets (genes, proteins) that were previously unknown or overlooked.\\\\n    *   **Causal Inference:** AI is being used to move beyond mere correlation and identify causal relationships between biological entities and disease states, leading to more robust target selection.\\\\n    *   **Literature Mining:** Advanced natural language processing (NLP) models can scan vast amounts of scientific literature, patents, and clinical trial data to uncover hidden connections and suggest new targets.\\\\n\\\\n2.  **De Novo Drug Design and Molecular Generation:**\\\\n    *   **Generative AI Models (e.g., GANs, VAEs, Diffusion Models):** These models can \\\\\"learn\\\\\" the chemical rules of successful drugs and then generate entirely new molecular structures with desired properties (e.g., high binding affinity to a target, good bioavailability, low toxicity). This moves beyond screening existing libraries.\\\\n    *   **Property Prediction:** AI can predict a vast array of physicochemical and biological properties of newly generated molecules, filtering out unpromising candidates early on.\\\\n\\\\n3.  **Optimizing Lead Compound Identification and Optimization:**\\\\n    *   **Virtual Screening:** AI can rapidly screen billions of virtual compounds against a target, far faster and more cost-effectively than traditional high-throughput screening.\\\\n    *   **Structure-Activity Relationship (SAR) Modeling:** AI models can learn complex relationships between a molecule\\'s structure and its biological activity, guiding medicinal chemists to design more potent and selective drug candidates.\\\\n    *   **Multi-Objective Optimization:** AI can simultaneously optimize for multiple desired characteristics of a drug candidate, such as efficacy, safety, solubility, and metabolic stability, which is a complex challenge for human chemists.\\\\n\\\\n4.  **Repurposing Existing Drugs:**\\\\n    *   **Network Pharmacology:** AI can analyze complex biological networks to identify how existing drugs, approved for other conditions, might interact with new targets or pathways relevant to a different disease. This can significantly shorten the drug development timeline.\\\\n\\\\n5.  **Predicting Clinical Trial Success and Design:**\\\\n    *   **Patient Stratification:** AI can identify patient subgroups that are most likely to respond to a particular drug, leading to more efficient and successful clinical trials.\\\\n    *   **Trial Simulation:** AI can be used to simulate clinical trials to optimize dosing regimens, endpoints, and sample sizes before they are run in humans.\\\\n\\\\n6.  **AI for Specific Disease Areas:**\\\\n    *   **Oncology:** AI is heavily used to discover cancer drugs, identify new biomarkers for targeted therapies, and predict treatment response.\\\\n    *   **Neuroscience:** AI is helping to uncover targets for neurological disorders like Alzheimer\\'s and Parkinson\\'s, where understanding complex brain biology is crucial.\\\\n    *   **Infectious Diseases:** AI is playing a role in identifying new antibiotics and antivirals, especially in the face of growing antimicrobial resistance.\\\\n\\\\n**Examples of recent news and company activities you might see:**\\\\n\\\\n*   **Partnerships:** Major pharmaceutical companies (Pfizer, Novartis, AstraZeneca, etc.) are frequently announcing collaborations with AI drug discovery startups (e.g., Insilico Medicine, Recursion Pharmaceuticals, Exscientia).\\\\n*   **Breakthroughs in AI-Generated Drugs:** Companies are reporting the advancement of AI-designed drug candidates into pre-clinical and even early clinical trials. For example, AI has been used to discover novel treatments for fibrotic diseases, cancer, and infectious agents.\\\\n*   **New AI Platforms:** Development of increasingly sophisticated AI platforms that integrate various data types and machine learning techniques for a more holistic approach to drug discovery.\\\\n*   **Focus on \\\\\"Undruggable\\\\\" Targets:** AI is offering new hope for tackling complex biological targets that have historically been considered too difficult to drug using conventional methods.\\\\n\\\\n**In summary, AI is transforming drug discovery by:**\\\\n\\\\n*   **Speeding up the process:** Reducing the time from initial concept to potential drug candidate.\\\\n*   **Reducing costs:** By making research more efficient and reducing the failure rate in later stages.\\\\n*   **Increasing innovation:** By uncovering novel targets and designing entirely new molecules.\\\\n*   **Improving success rates:** By selecting better targets and designing drugs with higher probabilities of efficacy and safety.\\\\n\\\\nIt\\'s a field that\\'s constantly innovating, so expect to hear about more exciting discoveries and clinical advancements powered by AI in the near future!\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"Tell me more about the second development you found.\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'text_chat_bot', '{\"parts\": [{\"text\": \"You\\'re referring to **\\\\\"De Novo Drug Design and Molecular Generation\\\\\"**! This is a truly groundbreaking aspect of AI in drug discovery, moving beyond just analyzing what already exists to actively creating new possibilities.\\\\n\\\\nLet\\'s dive deeper into what this entails:\\\\n\\\\n**What is \\\\\"De Novo\\\\\" Drug Design?**\\\\n\\\\n\\\\\"De novo\\\\\" is a Latin phrase meaning \\\\\"from the beginning\\\\\" or \\\\\"anew.\\\\\" In the context of drug discovery, de novo design means creating entirely new molecular structures that have never been synthesized or tested before, with the specific goal of interacting with a particular biological target to achieve a therapeutic effect.\\\\n\\\\n**How AI Enables De Novo Design:**\\\\n\\\\nTraditional drug discovery often relies on:\\\\n*   **Screening existing compound libraries:** Testing thousands or millions of pre-made molecules to see if any have activity.\\\\n*   **Modifying known drugs:** Making small chemical changes to existing successful drugs to improve their properties.\\\\n\\\\nAI, particularly **generative AI models**, revolutionizes this by allowing us to *design* molecules from scratch, guided by desired properties. Here are the key AI technologies involved:\\\\n\\\\n1.  **Generative Adversarial Networks (GANs):**\\\\n    *   **How they work:** GANs consist of two neural networks: a \\\\\"generator\\\\\" and a \\\\\"discriminator.\\\\\" The generator tries to create new molecular structures, while the discriminator tries to distinguish between real, valid molecules and the ones the generator creates. They learn through this \\\\\"adversarial\\\\\" process.\\\\n    *   **In drug discovery:** The generator learns the \\\\\"grammar\\\\\" of valid chemical structures and can produce novel molecules. The discriminator ensures these generated molecules are chemically sound and resemble existing drug-like compounds.\\\\n\\\\n2.  **Variational Autoencoders (VAEs):**\\\\n    *   **How they work:** VAEs learn a compressed \\\\\"latent space\\\\\" representation of existing molecules. This latent space captures the essential features of molecular structures.\\\\n    *   **In drug discovery:** By sampling points from this latent space and decoding them, VAEs can generate new, diverse molecular structures. They are particularly good at exploring novel chemical space.\\\\n\\\\n3.  **Diffusion Models:**\\\\n    *   **How they work:** These models work by gradually adding noise to an image (or in this case, a molecular representation) until it\\'s pure noise, and then learning to reverse this process to reconstruct the original image from noise.\\\\n    *   **In drug discovery:** They can generate highly realistic and novel molecular structures by learning the underlying distribution of chemical data. They\\'ve shown impressive results in generating molecules with specific properties.\\\\n\\\\n4.  **Reinforcement Learning (RL):**\\\\n    *   **How it\\'s used:** RL can be combined with generative models. The generative model proposes molecules, and the RL agent rewards (or penalizes) it based on how well the molecule meets specific predefined criteria (e.g., binding affinity to a target, low toxicity, good solubility).\\\\n    *   **In drug discovery:** This is crucial for guiding the generative process towards molecules that are not only chemically valid but also possess desired drug-like properties.\\\\n\\\\n**The Process Typically Looks Like This:**\\\\n\\\\n1.  **Define the Target:** Identify the specific protein or biological pathway that the drug needs to interact with.\\\\n2.  **Specify Desired Properties:** Define the characteristics the new drug molecule should have (e.g., high affinity for the target, good oral bioavailability, minimal off-target effects, ease of synthesis).\\\\n3.  **Train the Generative Model:** The AI model is trained on a vast dataset of existing molecules and their properties.\\\\n4.  **Generate Candidates:** The trained model proposes novel molecular structures.\\\\n5.  **Filter and Refine:** AI models predict the properties of the generated molecules. Those that meet the criteria are selected for further analysis.\\\\n6.  **Virtual Testing:** Promising candidates are subjected to virtual binding assays and other simulations.\\\\n7.  **Experimental Validation:** The most promising AI-designed molecules are then synthesized in the lab and experimentally tested.\\\\n\\\\n**Why is this so significant?**\\\\n\\\\n*   **Exploration of Novel Chemical Space:** AI can create molecules that human intuition might not have conceived, potentially leading to entirely new classes of drugs.\\\\n*   **Efficiency:** It dramatically speeds up the identification of starting points for drug development compared to traditional screening methods.\\\\n*   **Tailored Solutions:** It allows for the design of molecules optimized for specific targets and patient populations.\\\\n*   **Overcoming \\\\\"Undruggable\\\\\" Targets:** AI can generate novel molecular shapes and interaction patterns that might be able to bind to targets previously considered too difficult to drug.\\\\n\\\\nCompanies like **Insilico Medicine** and **Exscientia** are prominent examples that have successfully employed de novo AI design to discover drug candidates that have progressed into clinical trials. This approach represents a paradigm shift in how we discover medicines, moving from searching to creating.\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', None)\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"Who are the main companies involved in that?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'text_chat_bot', '{\"parts\": [{\"text\": \"The field of AI in healthcare is experiencing rapid and exciting advancements! Here\\'s a summary of some of the latest and most significant news:\\\\n\\\\n**1. Drug Discovery and Development Acceleration:**\\\\n\\\\n*   **AI identifying new drug targets:** Several companies and research institutions are using AI to analyze vast datasets of biological and chemical information to pinpoint novel drug targets for diseases like cancer, Alzheimer\\'s, and rare genetic disorders.\\\\n*   **Predicting drug efficacy and safety:** AI algorithms are becoming more sophisticated at predicting how effective a potential drug will be and identifying potential side effects early in the development process, saving time and resources.\\\\n*   **Personalized medicine breakthroughs:** AI is crucial in analyzing individual patient data (genomics, lifestyle, medical history) to predict responses to specific treatments, leading to more personalized and effective therapeutic strategies.\\\\n\\\\n**2. Enhanced Diagnostics and Imaging Analysis:**\\\\n\\\\n*   **AI in radiology:** AI models are demonstrating impressive accuracy in detecting anomalies in medical images like X-rays, CT scans, and MRIs, often spotting subtle signs that might be missed by the human eye. This is particularly impactful in areas like cancer screening (breast, lung) and stroke detection.\\\\n*   **Pathology advancements:** AI is being used to analyze pathology slides, assisting pathologists in identifying cancerous cells and grading tumors, leading to faster and more consistent diagnoses.\\\\n*   **Early disease detection:** AI is showing promise in analyzing various data points (wearable sensor data, electronic health records) to predict the onset of diseases like diabetes, heart disease, and even mental health conditions before symptoms become severe.\\\\n\\\\n**3. Streamlining Clinical Workflows and Operations:**\\\\n\\\\n*   **AI-powered virtual assistants and chatbots:** These tools are being used for patient triage, appointment scheduling, answering common medical questions, and providing post-discharge support, freeing up healthcare professionals\\' time.\\\\n*   **Predictive analytics for hospital management:** AI is helping hospitals optimize staffing, predict patient no-shows, manage bed occupancy, and identify potential bottlenecks in workflows, leading to more efficient operations and cost savings.\\\\n*   **Automated administrative tasks:** AI is automating tasks like medical coding, prior authorization requests, and data entry, reducing administrative burden on healthcare staff.\\\\n\\\\n**4. Advancements in Robotics and AI-Assisted Surgery:**\\\\n\\\\n*   **Smarter surgical robots:** AI is enhancing surgical robots with improved navigation, precision, and even the ability to provide real-time guidance to surgeons based on pre-operative imaging and patient data.\\\\n*   **Minimally invasive procedures:** AI is contributing to the development and refinement of minimally invasive surgical techniques, leading to faster recovery times and reduced complications for patients.\\\\n\\\\n**5. Challenges and Ethical Considerations Remain:**\\\\n\\\\n*   **Data privacy and security:** Ensuring the secure and ethical handling of sensitive patient data is a paramount concern.\\\\n*   **Bias in AI algorithms:** AI models trained on biased data can perpetuate or even amplify existing health disparities. Researchers are actively working on developing fairer and more equitable AI systems.\\\\n*   **Regulatory hurdles:** The FDA and other regulatory bodies are working to establish clear guidelines for the approval and deployment of AI-powered medical devices and software.\\\\n*   **Integration into existing systems:** Seamlessly integrating new AI technologies into complex existing healthcare IT infrastructures remains a significant challenge.\\\\n*   **Clinician adoption and trust:** Building trust among healthcare professionals and ensuring they understand and can effectively utilize AI tools is crucial for widespread adoption.\\\\n\\\\n**In summary, the latest news highlights AI\\'s transformative potential across the entire healthcare spectrum, from discovering life-saving drugs to improving patient care delivery. While significant progress is being made, addressing the associated ethical and practical challenges will be key to unlocking its full promise.**\\\\n\\\\nTo get the absolute latest, I\\'d recommend checking reputable sources like:\\\\n\\\\n*   **Major Medical Journals:** *Nature Medicine*, *The Lancet*, *JAMA*, *NEJM* often publish groundbreaking AI in healthcare research.\\\\n*   **Reputable Tech and Healthcare News Outlets:** *STAT News*, *FierceHealthcare*, *MedCity News*, *TechCrunch*, *MIT Technology Review*.\\\\n*   **Conferences and Industry Reports:** Look for news emerging from major healthcare AI conferences and reports from organizations like HIMSS or Deloitte.\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"Are there any new developments in drug discovery?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'text_chat_bot', '{\"parts\": [{\"text\": \"Yes, absolutely! Drug discovery is one of the most dynamic and rapidly evolving areas where AI is making a profound impact. Here are some of the latest developments:\\\\n\\\\n**1. Accelerating Target Identification and Validation:**\\\\n\\\\n*   **AI for \\\\\"Undruggable\\\\\" Targets:** Traditionally, many disease-causing proteins were considered \\\\\"undruggable\\\\\" due to their complex structures or lack of clear binding sites. AI, particularly through deep learning, is now being used to analyze protein folding, interactions, and identify novel ways to target these challenging molecules.\\\\n*   **Uncovering Novel Biological Pathways:** AI can sift through massive amounts of genomic, proteomic, and transcriptomic data to identify previously unknown biological pathways involved in diseases. This opens up entirely new avenues for drug development.\\\\n*   **Predicting Disease Associations:** AI models are getting better at connecting genetic variations or molecular changes to specific diseases, helping researchers prioritize targets that are most likely to yield therapeutic benefits.\\\\n\\\\n**2. Revolutionizing Molecule Design and Optimization:**\\\\n\\\\n*   **Generative AI for Novel Molecules:** Instead of screening existing libraries, generative AI models (like those based on GANs or VAEs) can now *design* entirely new molecules with desired properties. These molecules can be optimized for efficacy, safety, and bioavailability from the outset.\\\\n*   **De Novo Drug Design:** This is the process of designing a drug molecule from scratch for a specific target. AI is significantly speeding this up by exploring vast chemical spaces far more efficiently than traditional methods.\\\\n*   **Predicting ADMET Properties:** AI is becoming increasingly accurate at predicting a drug\\'s Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties early in the discovery phase. This helps filter out candidates likely to fail later, saving immense time and cost.\\\\n\\\\n**3. Enhancing Preclinical and Clinical Trial Efficiency:**\\\\n\\\\n*   **Predicting Clinical Trial Success:** AI can analyze historical clinical trial data, patient characteristics, and drug properties to predict the likelihood of success for new drug candidates, helping companies make more informed decisions about which drugs to advance.\\\\n*   **Optimizing Trial Design:** AI can assist in designing more efficient clinical trials by identifying optimal patient populations, predicting patient recruitment rates, and even suggesting appropriate dosages.\\\\n*   **Identifying Biomarkers for Patient Stratification:** AI can analyze patient data to identify biomarkers that predict who is most likely to respond to a particular drug, leading to more targeted and effective trials.\\\\n*   **Repurposing Existing Drugs:** AI can scan vast databases of existing drugs and scientific literature to identify potential new uses for approved medications, a faster and often safer route to new treatments.\\\\n\\\\n**4. Advances in Specific Disease Areas:**\\\\n\\\\n*   **Oncology:** AI is being extensively used to identify new cancer targets, design personalized cancer therapies, and predict patient response to immunotherapies.\\\\n*   **Neurological Disorders:** AI is showing promise in discovering drugs for Alzheimer\\'s, Parkinson\\'s, and other neurodegenerative diseases by analyzing complex brain imaging and genetic data.\\\\n*   **Infectious Diseases:** AI is accelerating the discovery of new antibiotics and antivirals, which is critical in the face of growing antimicrobial resistance.\\\\n\\\\n**Key Players and Trends:**\\\\n\\\\nSeveral innovative companies are at the forefront of this revolution, including:\\\\n\\\\n*   **Recursion Pharmaceuticals:** Uses AI and automation to map human biology and discover drugs.\\\\n*   **Exscientia:** Focuses on AI-driven drug design and development.\\\\n*   **Insilico Medicine:** Leverages AI for target discovery, drug design, and clinical development.\\\\n*   **Atomwise:** Uses deep learning for small molecule drug discovery.\\\\n*   **BenevolentAI:** Employs AI to identify novel drug targets and accelerate research.\\\\n\\\\n**Challenges and the Road Ahead:**\\\\n\\\\nDespite these exciting advancements, challenges remain:\\\\n\\\\n*   **Data Quality and Accessibility:** High-quality, diverse, and standardized data is crucial for training effective AI models.\\\\n*   **Interpretability of AI Models:** Understanding *why* an AI model makes a certain prediction is important for building trust and ensuring safety.\\\\n*   **Regulatory Approval:** Navigating the regulatory pathways for AI-discovered drugs is an ongoing process.\\\\n*   **Bridging the Gap to the Clinic:** Successfully translating AI-generated insights into safe and effective human therapies still requires rigorous experimental validation.\\\\n\\\\nIn conclusion, AI is not just incrementally improving drug discovery; it\\'s fundamentally transforming the process, making it faster, more efficient, and opening up possibilities for treating diseases that were previously considered intractable. The pace of innovation in this space is truly remarkable!\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'text_chat_bot', '{\"parts\": [{\"text\": \"You\\'re asking about the latest news again! It\\'s a rapidly evolving field, so let\\'s dive into some of the most recent and impactful developments in AI in healthcare:\\\\n\\\\n**1. Generative AI\\'s Growing Role:**\\\\n\\\\n*   **Synthetic Data Generation:** A significant trend is the use of generative AI to create synthetic medical data. This is crucial for training AI models when real patient data is scarce, sensitive, or biased. Synthetic data can mimic real-world distributions, improving model robustness without compromising privacy.\\\\n*   **AI-Assisted Medical Writing:** Generative AI is being used to draft initial versions of clinical trial reports, research papers, patient summaries, and even radiology reports. This can significantly reduce the documentation burden on clinicians.\\\\n*   **Personalized Patient Education:** AI chatbots are becoming more sophisticated, capable of generating tailored explanations of complex medical conditions, treatment plans, and medication instructions in a way that patients can easily understand.\\\\n\\\\n**2. Advanced Diagnostics and Predictive Analytics:**\\\\n\\\\n*   **AI for Early Sepsis Detection:** Several systems are now being deployed or trialed that use AI to continuously monitor patient vital signs and EHR data to predict the onset of sepsis much earlier than traditional methods, allowing for quicker intervention and better outcomes.\\\\n*   **AI in Ophthalmology:** AI algorithms are showing remarkable accuracy in detecting diabetic retinopathy, glaucoma, and macular degeneration from retinal scans, enabling earlier diagnosis and treatment, especially in underserved areas.\\\\n*   **Predicting Hospital Readmissions:** AI models are getting better at identifying patients at high risk of readmission after discharge, allowing hospitals to implement targeted interventions and post-discharge care to prevent unnecessary returns.\\\\n*   **AI for Mental Health Assessment:** AI is being explored for analyzing speech patterns, facial expressions, and text-based communications to identify early signs of depression, anxiety, and other mental health conditions.\\\\n\\\\n**3. Enhancing Clinical Decision Support:**\\\\n\\\\n*   **AI-Powered Treatment Recommendations:** AI systems are being developed to analyze a patient\\'s full medical profile, along with the latest clinical evidence, to provide clinicians with evidence-based treatment recommendations. This is particularly valuable for complex or rare conditions.\\\\n*   **Drug Interaction Prediction:** AI is being used to identify potential harmful drug-drug interactions that might be missed by human review, especially in patients taking multiple medications.\\\\n*   **Personalized Dosing:** AI can help optimize drug dosages for individual patients by considering factors like genetics, metabolism, and response to previous treatments.\\\\n\\\\n**4. Streamlining Healthcare Operations and Workflow:**\\\\n\\\\n*   **AI for Prior Authorization:** Many healthcare systems are implementing AI solutions to automate and expedite the prior authorization process for medical procedures and prescriptions, which is a major administrative bottleneck.\\\\n*   **Optimizing Resource Allocation:** AI is being used to predict patient flow, optimize staffing levels, and manage equipment utilization in hospitals, leading to more efficient operations and reduced costs.\\\\n*   **AI in Revenue Cycle Management:** AI is helping to improve medical coding accuracy, detect fraud and abuse, and streamline billing processes.\\\\n\\\\n**5. Ethical and Regulatory Focus:**\\\\n\\\\n*   **FDA\\'s Evolving Framework:** The FDA continues to refine its approach to regulating AI/ML-based medical devices, with a focus on ensuring ongoing safety and effectiveness as models learn and evolve. They are actively engaging with industry to establish clear pathways for approval and post-market surveillance.\\\\n*   **Addressing Algorithmic Bias:** There\\'s a continued and intensified focus on identifying and mitigating bias in AI algorithms to ensure equitable healthcare for all patient populations. This includes developing fairness metrics and diverse training datasets.\\\\n*   **Data Governance and Security:** As AI adoption grows, robust data governance frameworks and advanced cybersecurity measures are becoming even more critical to protect sensitive patient information.\\\\n\\\\n**Key Takeaway:** The trend is towards AI moving beyond research labs and into practical, day-to-day clinical and operational settings. Generative AI is a particularly hot area, with the potential to revolutionize how information is created and consumed in healthcare. However, the ethical considerations and the need for robust regulatory oversight remain paramount.\\\\n\\\\nFor the absolute latest, keeping an eye on publications from organizations like the FDA, major medical associations, and leading AI/healthcare technology news outlets is your best bet!\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', None)\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"Are there any new developments in drug discovery?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'compaction_demo', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n",
      "('research_app_compacting', 'research_db_session_v1', 'user', '{\"parts\": [{\"text\": \"What is the latest news about AI in healthcare?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n"
     ]
    }
   ],
   "source": [
    "import sqlite3\n",
    "\n",
    "def check_data_in_db():\n",
    "    with sqlite3.connect(\"my_agent_data.db\") as connection:\n",
    "        cursor = connection.cursor()\n",
    "        result = cursor.execute(\n",
    "            \"select app_name, session_id, author, content from events\"\n",
    "        )\n",
    "        print([_[0] for _ in result.description])\n",
    "        for each in result.fetchall():\n",
    "            print(each)\n",
    "\n",
    "\n",
    "check_data_in_db()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "#### Section 4: Context Compaction\n",
    "\n",
    "all the events are stored in full in the session Database, and this quickly adds up. For a long, complex task, this lists events can become very large, leading to slower performance and higher costs.\n",
    "\n",
    "But what if we could automatically summarize the past? Let's using ADK's **Context Compaction** feature to see "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T18:04:50.876587Z",
     "iopub.status.busy": "2025-11-29T18:04:50.876244Z",
     "iopub.status.idle": "2025-11-29T18:04:50.886146Z",
     "shell.execute_reply": "2025-11-29T18:04:50.885235Z",
     "shell.execute_reply.started": "2025-11-29T18:04:50.876564Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Research App upgraded with Events Compaction!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\HP\\AppData\\Local\\Temp\\ipykernel_12572\\279560604.py:5: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n",
      "  events_compaction_config=EventsCompactionConfig(\n"
     ]
    }
   ],
   "source": [
    "\n",
    "research_app_compacting = App(\n",
    "    name=\"research_app_compacting\",\n",
    "    root_agent=chatbot_agent,\n",
    "    \n",
    "    events_compaction_config=EventsCompactionConfig(\n",
    "        compaction_interval=3,  \n",
    "        overlap_size=1,  \n",
    "    ),\n",
    ")\n",
    "\n",
    "db_url = \"sqlite:///my_agent_data.db\"  \n",
    "session_service = DatabaseSessionService(db_url=\"sqlite+aiosqlite:///my_agent_data.db\")\n",
    "research_runner_compacting = Runner(\n",
    "    app=research_app_compacting, session_service=session_service\n",
    ")\n",
    "\n",
    "\n",
    "print(\" Research App upgraded with Events Compaction!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Research App using DatabaseSessionService\n"
     ]
    }
   ],
   "source": [
    "from google.adk.apps.app import App  \n",
    "from google.adk.sessions import DatabaseSessionService\n",
    "from google.adk.runners import Runner\n",
    "\n",
    "research_app_compacting = App(\n",
    "    name=\"research_app_compacting\",\n",
    "    root_agent=chatbot_agent,\n",
    "\n",
    ")\n",
    "\n",
    "\n",
    "db_url = \"sqlite+aiosqlite:///my_agent_data.db\"\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "\n",
    "research_runner_compacting = Runner(\n",
    "    app=research_app_compacting,\n",
    "    session_service=session_service,\n",
    ")\n",
    "\n",
    "print(\" Research App using DatabaseSessionService\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: research_db_session_v2\n",
      "\n",
      "User > What is the latest news about AI in healthcare?\n",
      "gemini-2.5-flash-lite >  Here's a summary of the latest news and trends in AI in healthcare:\n",
      "\n",
      "**Key Areas of Advancement and Investment:**\n",
      "\n",
      "*   **Drug Discovery and Development:** This remains a hot area. AI is being used to:\n",
      "    *   **Identify novel drug targets:** Analyzing vast biological datasets to find new proteins or pathways associated with diseases.\n",
      "    *   **Design new molecules:** Predicting the properties of potential drug candidates and designing novel compounds with desired efficacy and safety profiles.\n",
      "    *   **Accelerate clinical trials:** Identifying suitable patient cohorts, predicting trial outcomes, and optimizing trial design, potentially reducing costs and timelines.\n",
      "    *   **Recent examples:** Companies like Insilico Medicine, BenevolentAI, and Recursion Pharmaceuticals are making significant strides and securing substantial funding.\n",
      "\n",
      "*   **Medical Imaging and Diagnostics:** AI continues to revolutionize how medical images are analyzed:\n",
      "    *   **Radiology:** AI algorithms are increasingly adept at detecting anomalies in X-rays, CT scans, MRIs, and mammograms, often with comparable or even superior accuracy to human radiologists, acting as a second pair of eyes.\n",
      "    *   **Pathology:** AI is being used to analyze tissue samples, identify cancerous cells, and grade tumors.\n",
      "    *   **Ophthalmology:** AI is proving effective in detecting conditions like diabetic retinopathy and glaucoma from retinal scans.\n",
      "    *   **Challenges:** Regulatory approval, integration into clinical workflows, and ensuring generalizability across different patient populations and imaging equipment are ongoing considerations.\n",
      "\n",
      "*   **Personalized Medicine and Treatment Planning:**\n",
      "    *   **Genomics and Precision Oncology:** AI is crucial for analyzing complex genomic data to understand individual patient responses to treatments and tailor therapies accordingly.\n",
      "    *   **Predictive Analytics:** AI models are being developed to predict patient risk for certain diseases (e.g., sepsis, heart failure, readmission) allowing for early intervention.\n",
      "    *   **Treatment Optimization:** AI can help clinicians determine the optimal dosage and combination of treatments based on a patient's unique characteristics.\n",
      "\n",
      "*   **Virtual Assistants and Patient Engagement:**\n",
      "    *   **Symptom Checkers and Triage:** AI-powered chatbots are becoming more sophisticated in helping patients understand their symptoms and guiding them to appropriate care.\n",
      "    *   **Remote Patient Monitoring:** AI can analyze data from wearable devices and other sensors to track patient health, detect deviations, and alert caregivers.\n",
      "    *   **Administrative Tasks:** AI is automating tasks like appointment scheduling, medical coding, and processing insurance claims, freeing up healthcare professionals.\n",
      "\n",
      "*   **Robotics in Surgery:**\n",
      "    *   **AI-assisted Robotic Surgery:** While not entirely AI-driven, AI is enhancing robotic surgical systems by providing real-time guidance, improving precision, and analyzing surgical performance.\n",
      "\n",
      "**Emerging Trends and Considerations:**\n",
      "\n",
      "*   **Explainable AI (XAI):** There's a growing demand for AI models that can explain their reasoning, especially in critical healthcare decisions. This is crucial for building trust among clinicians and regulators.\n",
      "*   **Federated Learning:** This approach allows AI models to be trained on decentralized data sources (e.g., across different hospitals) without compromising patient privacy.\n",
      "*   **AI in Mental Health:** AI is being explored for early detection of mental health conditions, personalized therapy recommendations, and even as therapeutic tools.\n",
      "*   **Regulatory Landscape:** Regulatory bodies like the FDA are actively developing frameworks for approving AI-powered medical devices and software. The speed of innovation often outpaces regulation, leading to ongoing discussions.\n",
      "*   **Data Privacy and Security:** As AI relies on vast amounts of patient data, robust measures for data privacy, security, and ethical use are paramount.\n",
      "*   **Addressing Bias:** Ensuring AI algorithms are fair and do not perpetuate or amplify existing healthcare disparities is a critical area of focus.\n",
      "\n",
      "**Where to Find More Specific News:**\n",
      "\n",
      "*   **Major Tech Companies:** Google, Microsoft, IBM, Amazon, and Apple are all investing heavily in AI for healthcare.\n",
      "*   **Biotech and Pharma Companies:** Many are partnering with AI firms or developing their own internal AI capabilities.\n",
      "*   **Academic Research Institutions:** Universities are at the forefront of AI research in healthcare.\n",
      "*   **Healthcare Technology News Outlets:** Websites like FierceBiotech, STAT News, MobiHealthNews, and Healthcare IT News provide regular updates.\n",
      "*   **Medical Journals:** Publications like Nature Medicine, The Lancet Digital Health, and JAMA often feature groundbreaking AI research.\n",
      "\n",
      "**In summary, AI in healthcare is rapidly evolving, moving from theoretical potential to practical applications that promise to improve diagnostics, accelerate drug discovery, personalize treatments, and streamline operations. However, challenges related to regulation, explainability, data privacy, and bias remain active areas of development and discussion.**\n",
      "\n",
      " ### Session: research_db_session_v2\n",
      "\n",
      "User > Are there any new developments in drug discovery?\n",
      "gemini-2.5-flash-lite >  Yes, there are constant and exciting new developments in AI-driven drug discovery! It's one of the most dynamic areas of AI in healthcare. Here are some of the latest trends and breakthroughs:\n",
      "\n",
      "**1. Generative AI for Novel Molecule Design:**\n",
      "\n",
      "*   **Beyond Screening:** Instead of just screening existing libraries of compounds, generative AI models can now *design entirely new molecules* from scratch with desired properties. These models learn the \"rules\" of molecular structure and can propose novel candidates that might not have been conceived through traditional methods.\n",
      "*   **Targeting Specific Properties:** Researchers are using AI to generate molecules optimized for specific characteristics like binding affinity to a target protein, solubility, or reduced toxicity.\n",
      "*   **Examples:** Companies like **Recursion Pharmaceuticals**, **Insilico Medicine**, and **Absci** are heavily leveraging generative AI for this purpose. Insilico Medicine, for example, has a drug candidate for idiopathic pulmonary fibrosis that was discovered and designed using AI, and is now in clinical trials.\n",
      "\n",
      "**2. Enhanced Target Identification and Validation:**\n",
      "\n",
      "*   **Multi-omics Integration:** AI is becoming incredibly powerful at integrating vast datasets from genomics, proteomics, transcriptomics, and clinical data to identify novel disease targets that might be missed by single-data analyses.\n",
      "*   **Pathway Analysis:** AI can map complex biological pathways and identify critical nodes or dysregulations that represent promising drug targets.\n",
      "*   **Predicting Target Druggability:** AI models are being developed to predict whether a newly identified target is likely to be \"druggable\"  meaning a molecule can effectively bind to it and modulate its function.\n",
      "\n",
      "**3. Accelerating Pre-clinical and Clinical Trials:**\n",
      "\n",
      "*   **Predictive Toxicology:** AI is being used to predict potential toxicity of drug candidates earlier in the development process, saving time and resources by weeding out problematic compounds sooner.\n",
      "*   **Biomarker Discovery:** AI can identify subtle biomarkers in patient data that predict response to a drug or indicate disease progression, which is crucial for stratifying patients in clinical trials.\n",
      "*   **Virtual Clinical Trials:** AI can simulate aspects of clinical trials, helping to optimize trial design, predict outcomes, and potentially reduce the need for certain in-person studies.\n",
      "*   **\"In Silico\" Experimentation:** AI is being used to perform virtual experiments that mimic biological assays, speeding up the initial screening and testing phases.\n",
      "\n",
      "**4. AI for Protein Folding and Structure Prediction:**\n",
      "\n",
      "*   **AlphaFold and its Successors:** DeepMind's AlphaFold has been a game-changer, accurately predicting protein structures. This has profound implications for drug discovery because understanding a protein's 3D shape is essential for designing drugs that can bind to it effectively.\n",
      "*   **Drug Design Based on Structure:** With accurate protein structures readily available, AI can now be more precisely used to design molecules that fit into specific binding pockets of disease-related proteins.\n",
      "\n",
      "**5. Real-World Evidence (RWE) for Drug Repurposing and Optimization:**\n",
      "\n",
      "*   **Finding New Uses for Old Drugs:** AI can analyze vast amounts of RWE (data from electronic health records, insurance claims, wearables, etc.) to identify existing drugs that might be effective for new indications (drug repurposing). This can significantly shorten the development timeline and reduce costs.\n",
      "*   **Optimizing Dosing and Combinations:** AI can help understand how drugs perform in real-world populations, leading to better insights on optimal dosing and combination therapies.\n",
      "\n",
      "**6. Advancements in Small Molecule and Biologics Discovery:**\n",
      "\n",
      "*   **Small Molecules:** AI is excelling at designing small molecules with improved potency, selectivity, and pharmacokinetic properties.\n",
      "*   **Biologics (e.g., Antibodies, Proteins):** AI is also being applied to design novel antibodies, peptides, and other protein-based therapeutics with enhanced therapeutic profiles.\n",
      "\n",
      "**Key Players and Trends:**\n",
      "\n",
      "*   **AI-Native Biotech Companies:** Companies like **Insilico Medicine**, **BenevolentAI**, **Atomwise**, **Exscientia**, and **Schrdinger** are built around AI and are making significant progress.\n",
      "*   **Big Pharma Partnerships:** Major pharmaceutical companies (e.g., Pfizer, Novartis, GSK, Merck) are actively partnering with or acquiring AI drug discovery companies to integrate these technologies into their pipelines.\n",
      "*   **Focus on Specific Diseases:** Many AI efforts are now targeting complex diseases like neurodegenerative disorders (Alzheimer's, Parkinson's), rare diseases, and difficult-to-treat cancers.\n",
      "\n",
      "**In essence, AI is transforming drug discovery from a largely empirical, trial-and-error process into a more rational, data-driven, and predictive endeavor. This is leading to faster timelines, reduced costs, and the potential to discover novel therapies for diseases that were previously untreatable.**\n"
     ]
    }
   ],
   "source": [
    "SESSION_NAME = \"research_db_session_v2\"\n",
    "\n",
    "\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"What is the latest news about AI in healthcare?\",\n",
    "    SESSION_NAME,\n",
    ")\n",
    "\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Are there any new developments in drug discovery?\",\n",
    "    SESSION_NAME,\n",
    ")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Verifying Compaction in the Session History\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-11-29T18:05:56.151890Z",
     "iopub.status.busy": "2025-11-29T18:05:56.151561Z",
     "iopub.status.idle": "2025-11-29T18:05:56.163652Z",
     "shell.execute_reply": "2025-11-29T18:05:56.162695Z",
     "shell.execute_reply.started": "2025-11-29T18:05:56.151862Z"
    },
    "trusted": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Searching for Compaction Summary Event ---\n",
      "\n",
      " SUCCESS! Found the Compaction Event:\n",
      "  Author: user\n",
      "\n",
      " Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='815e1eb7-7801-4ec6-8b80-0261c922f818' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1764463265.725412, 'end_timestamp': 1764463273.409589, 'compacted_content': {'parts': [{'media_resolution': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_call': None, 'function_response': None, 'inline_data': None, 'text': 'This conversation history centers on the user\\'s interest in AI advancements in healthcare, specifically focusing on drug discovery.\\n\\n**Key Information and Decisions:**\\n\\n*   **Initial Inquiry:** The user first asked for \"latest news about AI in healthcare.\"\\n*   **AI\\'s Response:** The AI provided a broad overview of AI\\'s impact across various healthcare domains (drug discovery, diagnostics, patient care, operations, generative AI) and highlighted recent trends like FDA approvals and increased investment.\\n*   **User\\'s Specific Interest:** The user then narrowed their focus to \"new developments in drug discovery.\"\\n*   **AI\\'s Detailed Response on Drug Discovery:** The AI provided a comprehensive explanation of how AI is revolutionizing drug discovery, covering target identification, de novo design, lead optimization, drug repurposing, and clinical trial prediction.\\n*   **User\\'s Follow-up:** The user requested more information about the \"second development\" mentioned, which was identified as \"De Novo Drug Design and Molecular Generation.\"\\n*   **AI\\'s Deep Dive into De Novo Design:** The AI elaborated on de novo drug design, explaining its meaning, the AI technologies involved (GANs, VAEs, Diffusion Models, Reinforcement Learning), the typical process, and its significance.\\n\\n**Unresolved Questions or Tasks:**\\n\\n*   The conversation is currently focused on de novo drug design. The user has not explicitly asked for further clarification or indicated a desire to move to another topic. Therefore, the interaction is effectively paused, awaiting the user\\'s next prompt. There are no outstanding tasks or unresolved questions from the AI\\'s perspective, other than potentially providing more examples or delving into other aspects of AI in drug discovery if the user wishes.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='634b3bc9-0136-4042-95e9-ab4fb4c991e2' timestamp=1764463280.154401\n"
     ]
    }
   ],
   "source": [
    "\n",
    "final_session = await session_service.get_session(\n",
    "    app_name=research_runner_compacting.app_name,\n",
    "    user_id=USER_ID,\n",
    "    session_id=\"compaction_demo\",\n",
    ")\n",
    "\n",
    "print(\"--- Searching for Compaction Summary Event ---\")\n",
    "found_summary = False\n",
    "for event in final_session.events:\n",
    "   \n",
    "    if event.actions and event.actions.compaction:\n",
    "        print(\"\\n SUCCESS! Found the Compaction Event:\")\n",
    "        print(f\"  Author: {event.author}\")\n",
    "        print(f\"\\n Compacted information: {event}\")\n",
    "        found_summary = True\n",
    "        break\n",
    "\n",
    "if not found_summary:\n",
    "    print(\n",
    "        \"\\n No compaction event found. Try increasing the number of turns in the demo.\"\n",
    "    )"
   ]
  }
 ],
 "metadata": {
  "kaggle": {
   "accelerator": "none",
   "dataSources": [],
   "isGpuEnabled": false,
   "isInternetEnabled": true,
   "language": "python",
   "sourceType": "notebook"
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
